Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S24 pseudogene 9 (RPS24P9) is a processed pseudogene found in the human genome. It is genomically similar to the ribosomal protein S24 gene, but due to its lack of critical regulatory and coding sequences, it is not translated into a functional protein. Pseudogenes such as RPS24P9 typically arise from duplication or retrotransposition events and may serve limited regulatory roles, but they do not have direct activities in cellular processes nor are they generally considered therapeutic targets. The functional gene RPS24, by contrast, encodes a component of the 40S ribosomal subunit involved in protein synthesis, and mutations there are linked to Diamond-Blackfan anemia and certain cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S24 pseudogene 9 (RPS24P9).